Bicara Therapeutics Inc Common Stock
Price & Volume
Stats
See more52W Range | $9.57-$30.99 |
Market Cap | $1.8B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.77 |
News
See moreYahoo Finance • 4 months ago
Morning Movers: Sysco dips following deal to acquire Jetro Restaurant Depot
Yahoo Finance • 4 months ago
Bicara Therapeutics Q4 Earnings Call Highlights
Yahoo Finance • 4 months ago
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Yahoo Finance • 4 months ago
Bicara Therapeutics CEO Quietly Sold Shares. Her 339,000-Share Stake Speaks Louder.
About
CEO | Dr. Claire Mazumdar Clemon M.B.A., Ph.D. |
CFO | Mr. Ivan Hyep M.B.A. |
Address | 116 Huntington Avenue, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |